The main risks are not product viability but value capture and timing. Credo has proven products, margins, and AI relevance, yet shareholder outcomes remain highly sensitive to a small group of customer ramps, outsourced optical supply, and whether the company can defend premium pricing as larger rivals and
hyperscalers broaden their own interconnect stacks.